Patanjali and Divya Pharmacy – is India’s top brand in Ayurvedic sector. Moreover, the products have always been used across the country. Surprisingly, the government of Nepal has blacklisted and banned the Patanjali and Divya Pharmacy products, along with 16 other brands in the country.
As per the information, the department of drug administration asked the local govt to recall the supply of the products of these brands (Indian and foreign) on an immediate basis, according to the official notification issued on December 18. Moreover, the notification says that the products can neither be imported nor distributed in Nepal.
Also read: BookMyShow 2022: Diljit Dosanjh & Alan Walker Tops Artistes; KGF Chapter 2, RRR Most Watched Films!
Notably, the list also includes Radiant Parenterals Ltd, Mercury Laboratories Ltd, Alliance Biotech, Captab Biotec, Aglowmed Ltd, Zee Laboratories, Daffodils Pharmaceuticals, GLS Pharma, Unijules Life Science, Concept Pharmaceuticals, Shree Anand Life Sciences, IPCA laboratories, Cadila Healthcare Ltd, Dial Pharmaceuticals, and Mackur laboratories in addition to Ramdev Baba’s Divya Pharmacy. However, some overseas brands are also mentioned on the list.
What Is The Reason Behind The Ban?
According to media reports, on Tuesday, Nepal’s drug regulatory authority placed 16 Indian pharmaceutical companies as “blacklisted” for “failing” to meet the WHO (World Health Organization) standards for producing medicines.
Reportedly, the list was released following an inspection of the pharmaceutical businesses’ manufacturing facilities after they applied to sell their goods to Nepal, as per news agency PTI. Furthermore, the government deployed teams of drug inspectors to India in April and July to look into the production facilities of pharmaceutical companies which wanted to export their goods to Nepal.
Four cough syrups produced and sold by India’s Maiden Pharma—Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup—were the subject of a previous WHO medical product alert. According to reports, the four cough syrups were responsible for at least 66 child fatalities in The Gambia.
